New arrays are lighter, thinner and more flexible than current commercial arrays and have the potential to optimize Tumor Treating Fields dose ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback